The phosphate clamp: a small and independent motif for nucleic acid backbone recognition

The 1.7 Å X-ray crystal structure of the B-DNA dodecamer, [d(CGCGAATTCGCG)]2 (DDD)-bound non-covalently to a platinum(II) complex, [{Pt(NH3)3}2-µ-{trans-Pt(NH3)2(NH2(CH2)6NH2)2}](NO3)6 (1, TriplatinNC-A,) shows the trinuclear cation extended along the phosphate backbone and bridging the minor groove. The square planar tetra-am(m)ine Pt(II) units form bidentate N-O-N complexes with OP atoms, in a Phosphate Clamp motif. The geometry is conserved and the interaction prefers O2P over O1P atoms (frequency of interaction is O2P > O1P, base and sugar oxygens > N). The binding mode is very similar to that reported for the DDD and [{trans-Pt(NH3)2(NH2(CH2)6(NH3+)}2-µ-{trans-Pt(NH3)2(NH2(CH2)6NH2)2}](NO3)8 (3, TriplatinNC), which exhibits in vivo anti-tumour activity. In the present case, only three sets of Phosphate Clamps were found because one of the three Pt(II) coordination spheres was not clearly observed and was characterized as a bare Pt2+ ion. Based on the electron density, the relative occupancy of DDD and the sum of three Pt(II) atoms in the DDD-1 complex was 1:1.69, whereas the ratio for DDD-2 was 1:2.85, almost the mixing ratio in the crystallization drop. The high repetition and geometric regularity of the motif suggests that it can be developed as a modular nucleic acid binding device with general utility.

[1]  P. Lincoln,et al.  Self-assembly of functionalizable two-component 3D DNA arrays through the induced formation of DNA three-way-junction branch points by supramolecular cylinders. , 2010, Angewandte Chemie.

[2]  D. Arya,et al.  Triple recognition of B-DNA. , 2009, Bioorganic & medicinal chemistry letters.

[3]  T. Hamilton,et al.  Platinum Resistance: The Role of DNA Repair Pathways , 2008, Clinical Cancer Research.

[4]  L. Strekowski,,et al.  Noncovalent interactions with DNA: an overview. , 2007, Mutation research.

[5]  L. Kèlland,et al.  The resurgence of platinum-based cancer chemotherapy , 2007, Nature Reviews Cancer.

[6]  D. Stewart,et al.  Mechanisms of resistance to cisplatin and carboplatin. , 2007, Critical reviews in oncology/hematology.

[7]  J. Barton,et al.  Insights into finding a mismatch through the structure of a mispaired DNA bound by a rhodium intercalator , 2007, Proceedings of the National Academy of Sciences.

[8]  N. Farrell,et al.  A third mode of DNA binding: Phosphate clamps by a polynuclear platinum complex. , 2006, Journal of the American Chemical Society.

[9]  I. Usón,et al.  Molecular recognition of a three-way DNA junction by a metallosupramolecular helicate. , 2006, Angewandte Chemie.

[10]  N. Farrell,et al.  Biological Consequences of Trinuclear Platinum Complexes: Comparison of [{trans-PtCl(NH3)2}2μ-(trans-Pt(NH3)2(H2N(CH2)6-NH2)2)]4+ (BBR 3464) with Its Noncovalent Congeners , 2006, Molecular Pharmacology.

[11]  N. Farrell,et al.  Synthesis, characterization, and cytotoxicity of a novel highly charged trinuclear platinum compound. Enhancement of cellular uptake with charge. , 2005, Inorganic chemistry.

[12]  Eddie Reed ERCC1 and Clinical Resistance to Platinum-Based Therapy , 2005, Clinical Cancer Research.

[13]  N. Farrell,et al.  Unique cooperative binding interaction observed between a minor groove binding Pt antitumor agent and Hoechst dye 33258. , 2005, Inorganic chemistry.

[14]  L. Williams,et al.  High-resolution structure of an extended A-tract: [d(CGCAAATTTGCG)]2. , 2004, Journal of the American Chemical Society.

[15]  N. Farrell,et al.  Synthesis and DNA conformational changes of non-covalent polynuclear platinum complexes. , 2004, Journal of inorganic biochemistry.

[16]  N. Wheate,et al.  Potential adenine and minor groove binding platinum complexes. , 2004, Journal of inorganic biochemistry.

[17]  N. Farrell,et al.  Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure. , 2004, Journal of the American Chemical Society.

[18]  N. Farrell Polynuclear platinum drugs. , 2004, Metal ions in biological systems.

[19]  N. Gautham,et al.  Cobalt hexammine induced tautomeric shift in Z-DNA: the structure of d(CGCGCA)*d(TGCGCG) in two crystal forms. , 2004, Nucleic acids research.

[20]  J. Humphrey,et al.  Cancer Drug Discovery and Development , 2003 .

[21]  Adam P. Silverman,et al.  2.4-Å Crystal Structure of the Asymmetric Platinum Complex {Pt(ammine)(cyclohexylamine)}2+ Bound to a Dodecamer DNA Duplex* , 2002, The Journal of Biological Chemistry.

[22]  V. Brabec,et al.  DNA Interstrand Cross-links of the Novel Antitumor Trinuclear Platinum Complex BBR3464 , 2002, The Journal of Biological Chemistry.

[23]  V. Brabec,et al.  DNA Interstrand Crosslinks of the Novel Antitumor Trinuclear Platinum Complex BBR3464. Conformation, Recognition by HMG-Domain Proteins and Nucleotide Excision Repair* , 2002 .

[24]  N. Farrell,et al.  Cooperative effects in long-range 1,4 DNA-DNA interstrand cross-links formed by polynuclear platinum complexes: an unexpected syn orientation of adenine bases outside the binding sites , 2002, JBIC Journal of Biological Inorganic Chemistry.

[25]  S. Lippard,et al.  2.4 A crystal structure of an oxaliplatin 1,2-d(GpG) intrastrand cross-link in a DNA dodecamer duplex. , 2001, Inorganic chemistry.

[26]  T. Steitz,et al.  The kink‐turn: a new RNA secondary structure motif , 2001, The EMBO journal.

[27]  V. Brabec,et al.  Conformation, Recognition by High Mobility Group Domain Proteins, and Nucleotide Excision Repair of DNA Intrastrand Cross-links of Novel Antitumor Trinuclear Platinum Complex BBR3464* , 2001, The Journal of Biological Chemistry.

[28]  J. Collins,et al.  The binding of [(en)Pt(mu-dpzm)2Pt(en)]4+ to G/C-rich regions of DNA. , 2001, Journal of inorganic biochemistry.

[29]  N. Farrell,et al.  Kinetic analysis of the stepwise formation of a long-range DNA interstrand cross-link by a dinuclear platinum antitumor complex: evidence for aquated intermediates and formation of both kinetically and thermodynamically controlled conformers. , 2001, Journal of the American Chemical Society.

[30]  D. VanDerveer,et al.  Cations Mediate B-DNA Conformational Heterogeneity† , 2000 .

[31]  T. Steitz,et al.  The complete atomic structure of the large ribosomal subunit at 2.4 A resolution. , 2000, Science.

[32]  N. Farrell,et al.  BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[33]  N. Farrell,et al.  Platinum-Based Drugs in Cancer Therapy , 2000, Cancer Drug Discovery and Development.

[34]  D. Rees,et al.  Structure of a photoactive rhodium complex intercalated into DNA , 2000, Nature Structural Biology.

[35]  M. Egli,et al.  Atomic-resolution crystal structures of B-DNA reveal specific influences of divalent metal ions on conformation and packing. , 1999, Journal of molecular biology.

[36]  S. Lippard,et al.  Structure, Recognition, and Processing of Cisplatin-DNA Adducts. , 1999, Chemical reviews.

[37]  W. Shepard,et al.  Crystal structure of a double-stranded DNA containing a cisplatin interstrand cross-link at 1.63 A resolution: hydration at the platinated site. , 1999, Nucleic acids research.

[38]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[39]  G G Hu,et al.  The B-DNA dodecamer at high resolution reveals a spine of water on sodium. , 1998, Biochemistry.

[40]  H. Berman,et al.  Crystal and molecular structure of a new Z-DNA crystal form: d[CGT(2-NH2-A)CG] and its platinated derivative. , 1996, Biochemistry.

[41]  S. Lippard,et al.  Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin , 1995, Nature.

[42]  D. Wemmer,et al.  Complexes of the minor groove of DNA. , 1995, Annual review of biophysics and biomolecular structure.

[43]  R. Lavery,et al.  Measuring the geometry of DNA grooves , 1994, Biopolymers.

[44]  R Lavery,et al.  BI-BII transitions in B-DNA. , 1993, Nucleic acids research.

[45]  N. Farrell Nonclassical platinum antitumor agents: perspectives for design and development of new drugs complementary to cisplatin. , 1993, Cancer investigation.

[46]  B Tidor,et al.  Arginine-mediated RNA recognition: the arginine fork , 1991, Science.

[47]  B. Van Houten,et al.  Comparison of chemical reactivity, cytotoxicity, interstrand cross-linking and DNA sequence specificity of bis(platinum) complexes containing monodentate or bidentate coordination spheres with their monomeric analogues. , 1990, Biochemistry.

[48]  U Heinemann,et al.  Helix geometry, hydration, and G.A mismatch in a B-DNA decamer. , 1987, Science.

[49]  A. Rich,et al.  The interactions of ruthenium hexaammine with Z-DNA: crystal structure of a Ru(NH3)6+3 salt of d(CGCGCG) at 1.2 A resolution. , 1987, Journal of biomolecular structure & dynamics.

[50]  Richard E. Dickerson,et al.  Crystal structure analysis of a complete turn of B-DNA , 1980, Nature.

[51]  J. Trosko,et al.  Platinum Compounds: a New Class of Potent Antitumour Agents , 1969, Nature.

[52]  BARNETT ROSENBERG,et al.  Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode , 1965, Nature.